None EN

YolTech Therapeutics raises approximately $45m via Series B financing

NULL Pharmaceutical Business review 1900-01-01 00:00:00

The funds will help YolTech in advancing its clinical programmes and global strategic execution. Established in 2021, YolTech Therapeutics is stated to be advancing next-generation in vivo gene-editing The post YolTech Therapeutics raises approximately $45m via Series B financing appeared first on Pharmaceutical Business review.

yoltech therapeutics approximately financing raises series advancing appeared business clinical

Read Full Article Back to Feed More None